Starpharma Holdings Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.517x

Starpharma Holdings Ltd cash flow conversion efficiency. Based on the latest financial reports, Starpharma Holdings Ltd (SPL) has a cash flow conversion efficiency ratio of -0.517x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-7.12 Million ≈ $-5.04 Million USD) by net assets (AU$13.78 Million ≈ $9.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Starpharma Holdings Ltd (2001–2026)

Cash flow conversion efficiency of Starpharma Holdings Ltd from 2001 to 2026. This chart illustrates how Starpharma Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Starpharma Holdings Ltd (SPL) share price today for real-time trading data and today's change.

Starpharma Holdings Ltd Cash Flow Conversion Ratio Explained

Starpharma Holdings Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Starpharma Holdings Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Starpharma Holdings Ltd ranked by their cash flow conversion efficiency. Also see Starpharma Holdings Ltd (SPL) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Seven Hills Realty Trust NASDAQ:SEVN	0.014x
Centrum Medyczne ENEL-MED SA WAR:ENE	0.223x
Segro Plc LSE:SGRO	0.017x
Invesco Trust For Inv Grade NY Munis NYSE:VTN	0.022x
Polytronics Technology Corp TW:6224	0.010x
Powerwell Holdings Bhd KLSE:0217	0.106x
Intelligent Monitoring Group Ltd AU:IMB	0.149x
Genovis AB (publ.) ST:GENO	0.059x

Annual Cash Flow Conversion Efficiency for Starpharma Holdings Ltd (2001–2026)

The table below shows the annual cash flow conversion efficiency of Starpharma Holdings Ltd from 2001 to 2026. Review Starpharma Holdings Ltd (SPL) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-06-30	AU$13.78 Million ≈ $9.75 Million	AU$-3.21 Million ≈ $-2.27 Million	-0.233x	+34.51%
2025-06-30	AU$19.00 Million ≈ $13.44 Million	AU$-6.76 Million ≈ $-4.78 Million	-0.356x	-43.37%
2024-06-30	AU$28.12 Million ≈ $19.89 Million	AU$-6.98 Million ≈ $-4.94 Million	-0.248x	+36.16%
2023-06-30	AU$34.81 Million ≈ $24.63 Million	AU$-13.53 Million ≈ $-9.58 Million	-0.389x	-42.92%
2022-06-30	AU$48.39 Million ≈ $34.24 Million	AU$-13.16 Million ≈ $-9.31 Million	-0.272x	-14.43%
2021-06-30	AU$62.30 Million ≈ $44.08 Million	AU$-14.81 Million ≈ $-10.48 Million	-0.238x	+30.90%
2020-06-30	AU$31.33 Million ≈ $22.17 Million	AU$-10.78 Million ≈ $-7.62 Million	-0.344x	-40.99%
2019-06-30	AU$42.40 Million ≈ $30.00 Million	AU$-10.34 Million ≈ $-7.32 Million	-0.244x	-27.43%
2018-06-30	AU$53.28 Million ≈ $37.70 Million	AU$-10.20 Million ≈ $-7.22 Million	-0.191x	+31.13%
2017-06-30	AU$60.98 Million ≈ $43.15 Million	AU$-16.95 Million ≈ $-12.00 Million	-0.278x	+22.85%
2016-06-30	AU$49.42 Million ≈ $34.97 Million	AU$-17.81 Million ≈ $-12.60 Million	-0.360x	+0.59%
2015-06-30	AU$37.56 Million ≈ $26.57 Million	AU$-13.62 Million ≈ $-9.63 Million	-0.363x	-21.73%
2014-06-30	AU$32.95 Million ≈ $23.31 Million	AU$-9.81 Million ≈ $-6.94 Million	-0.298x	-39.76%
2013-06-30	AU$45.97 Million ≈ $32.53 Million	AU$-9.79 Million ≈ $-6.93 Million	-0.213x	-6.11%
2012-06-30	AU$48.65 Million ≈ $34.42 Million	AU$-9.77 Million ≈ $-6.91 Million	-0.201x	+14.13%
2011-06-30	AU$27.69 Million ≈ $19.59 Million	AU$-6.48 Million ≈ $-4.58 Million	-0.234x	-124.47%
2010-06-30	AU$34.84 Million ≈ $24.65 Million	AU$-3.63 Million ≈ $-2.57 Million	-0.104x	+34.07%
2009-06-30	AU$25.50 Million ≈ $18.04 Million	AU$-4.03 Million ≈ $-2.85 Million	-0.158x	+39.82%
2008-06-30	AU$20.38 Million ≈ $14.42 Million	AU$-5.35 Million ≈ $-3.79 Million	-0.263x	-99.82%
2007-06-30	AU$25.72 Million ≈ $18.20 Million	AU$-3.38 Million ≈ $-2.39 Million	-0.131x	+62.60%
2006-06-30	AU$21.32 Million ≈ $15.08 Million	AU$-7.49 Million ≈ $-5.30 Million	-0.351x	+39.71%
2005-06-30	AU$9.97 Million ≈ $7.05 Million	AU$-5.81 Million ≈ $-4.11 Million	-0.583x	-76.57%
2004-06-30	AU$17.59 Million ≈ $12.45 Million	AU$-5.81 Million ≈ $-4.11 Million	-0.330x	+22.04%
2002-06-30	AU$17.27 Million ≈ $12.22 Million	AU$-7.31 Million ≈ $-5.17 Million	-0.423x	-329.93%
2001-06-30	AU$24.92 Million ≈ $17.63 Million	AU$-2.45 Million ≈ $-1.74 Million	-0.098x	--

About Starpharma Holdings Ltd

AU:SPL Australia Biotechnology

Market Cap

$150.21 Million

AU$212.29 Million AUD

Market Cap Rank

#17394 Global

#508 in Australia

Share Price

AU$0.45

Change (1 day)

-3.26%

52-Week Range

AU$0.32 - AU$0.87

All Time High

AU$2.49